Articles tagged with Cannabis
Researchers found that cannabis use disorder is significantly associated with older age, male sex, black race, bipolar or other mood disorders, prior history of self-harm, and previous mental health service use. Cannabis use can worsen symptoms and interfere with successful mood disorder treatment.
Specialized ETFs focus on popular industries like cannabis and cybersecurity, but tend to lose value quickly. Investors who buy into these funds are often less sophisticated, leading to significant losses over time.
A new study by RAND Corporation found that the density of licensed and unlicensed marijuana retailers is associated with increased marijuana use among young adults. Young adults living near areas with high concentrations of licensed outlets were more likely to use marijuana, while those living near unlicensed outlets reported greater h...
A recent NIH study found that women who use cannabis while trying to conceive are around 40% less likely to get pregnant each month. The study of over 1,200 women aged 18-40 with one or two miscarriages found no difference in miscarriage rates but noted differences in reproductive hormones involved in ovulation.
Researchers found that exposure to acrolein, a chemical produced by tobacco combustion, increases cardiovascular disease risk; Higher levels of toxic chemicals were detected in tobacco smokers than marijuana only smokers. The study suggests reducing acrolein exposure could lower risk.
A new study found that marijuana use consistently increases throughout the calendar year, peaking during late fall or early winter before dropping at the beginning of the following year. The researchers believe this may be due to a 'Dry January' effect, where people stop using marijuana as part of a New Year's resolution.
A new study found that more than half of people using cannabis for pain experience clusters of multiple withdrawal symptoms when they're between uses. About 10% of patients experienced worsening changes in sleep, mood, mental state, energy, and appetite over two years.
A new study by Washington State University researchers found that chronic cannabis use significantly dampens stress reactivity in female rats, but not males. The study suggests there may be significant differences in how chronic cannabis use affects males and females.
Research suggests cannabis use by people in opioid addiction care can lower fentanyl-positive urine tests and reduce overdose risk. A study of 819 participants found that those with THC positive urine were 10% less likely to have fentanyl, highlighting potential benefits for treatment outcomes.
Levels of nicotine and marijuana vaping among US teens remained high in early 2020, despite a slight decrease in some trends. Nicotine vaping declined among 10th and 12th graders, but daily use remained high. The MTF survey found that vaping device brands have shifted, with teens moving to disposable devices.
A survey is being conducted to characterize marijuana use among cancer patients receiving care at MUSC Hollings Cancer Center. The study aims to explore how often patients are using marijuana, why they're using it, and their perceptions of its efficacy in managing symptoms. The findings will provide insight into the prevalence and spec...
Researchers found that ozone reacts with tetrahydrocannabinol (THC) on surfaces to produce new compounds. The study characterized these compounds for the first time and found they form over time, decreasing THC levels.
A landmark study led by the University of Sydney found that cannabidiol (CBD) in cannabis does not affect driving ability. In contrast, moderate amounts of tetrahydrocannabinol (THC) produce mild impairment lasting up to four hours.
A study of US adolescents aged 15-17 found that those who had not used substances exhibited enhanced neural responses when observing peers making safe choices. Peer influence was associated with safer health risk behaviors in adolescents.
The Association of Cannabis Specialists (ACS) has named Cannabis and Cannabinoid Research their Official Journal, providing evidence-based education and standards for cannabis medicine. The journal aims to enhance clinical best practices, safeguard patient care, and advance cannabinoid research.
The grants will focus on studying the impact of Proposition 64, employment conditions, and marketing on cannabis use among various demographics. UCLA faculty members will conduct research on workplace experiences, safety conditions, and career trajectory in the cannabis industry.
Over the past 50 years, cannabis strength has soared, with THC concentrations increasing by 14% in herbal cannabis and 24% in cannabis resin. This rise in potency is linked to an increased risk of problems such as addiction and psychotic disorders.
Researchers at USask are conducting a groundbreaking study to investigate the impact of maternal cannabis use during pregnancy on fetal brain development. They will be testing the hypothesis that chronic exposure to high-THC cannabis leads to increased anxiety and reduced cognition in rat pups.
Two studies presented at the American Heart Association's Scientific Sessions 2020 found that marijuana use is associated with a higher risk of stroke and post-procedure bleeding after PCI. However, marijuana smokers also experienced a decreased risk of acute kidney injury compared to non-users.
Researchers recommend that healthcare providers discuss cannabis use with patients who have chronic pain and are using opioids. This conversation should be routine and judgment-free. The goal is to understand the patient's priorities and develop a plan based on evidence-based information.
A modeling study estimates that treatments with ICERs above $100,000 to $150,000 per QALY are unlikely to be considered cost-effective for the US healthcare system. The study suggests that spending less on low-effectiveness treatments could allow more funding for treatments with larger health gains.
Research from Washington State University found that adolescent males associate cannabis use with improved sexual activity, leading them to express intentions to use marijuana. In contrast, female peers were less swayed by similar messages.
A Washington State University study found that cannabis use reduced OCD symptoms by 49% and anxiety by 52% within four hours. The study also linked higher CBD concentrations to larger reductions in compulsions.
A new study by neuroscientists at Washington State University found that regular cannabis exposure in rats during pregnancy may cause long-term cognitive deficiencies, asocial behavior, and anxiety in their offspring. The research also revealed significant behavioral changes and cognitive deficits that persisted into adulthood.
A new study by the University of Michigan and Texas State University found that more college-age Americans are abstaining from alcohol, with a significant decrease in alcohol misuse. However, the study also shows an increase in marijuana use and co-use of alcohol and marijuana.
A recent study found that regular exposure to marijuana advertising on storefronts and billboards increased the likelihood of adolescents using marijuana. Location of retail stores also played a role, with participants who lived close to shops being more likely to report intentions to use the drug.
A new study published in Addiction suggests that cannabis use does not substitute for non-medical opioids among adults with problem substance use. The longitudinal study of 211 participants found that opioid use was at least as high on days when cannabis was used as on days when it was not.
A recent study at Columbia University Mailman School of Public Health found that cannabis use is not a substitute for non-medical opioids among adults with opioid use disorder. The research examined 13,271 days of observation and found that opioid use remained prevalent on days when cannabis was used.
Research led by UTSW scientists finds that endocannabinoids can shut down genes needed for pathogenic intestinal bacteria to colonize and cause disease. The study suggests that these native chemicals similar to those found in cannabis may eventually lead to new ways to fight gastrointestinal infections.
A recent study found that 61% of patients who used cannabis began using it after age 60, primarily for medical purposes. The most common reasons for cannabis use were pain, insomnia, and anxiety, with patients reporting relief from these issues. The study highlights the need for healthcare professionals to be aware of cannabis use amon...
Patients who use cannabis before surgery require more anesthesia, report higher pain levels, and consume more opioids while in the hospital. Researchers emphasize the importance of disclosing cannabis use to anesthesiologists for optimal care.
A new study reveals that cannabis data is lacking on lesser-known compounds, but machine learning can help fill the knowledge gap. By analyzing a dataset of over 17,600 cultivars, researchers found that only 1.4% of strains had complete data on THC and CBD, highlighting the need for standardization in product labeling.
A new study finds that over half of women with menopause symptoms in Northern California are using cannabis to manage hot flashes, night sweats, and insomnia. The study also shows that more than a quarter of participants express interest in trying cannabis for menopause symptom management.
Researchers investigated cannabis use during pregnancy and found associations with childhood cognition, social problems and brain structure. The study suggests that marijuana use during pregnancy may have long-term effects on children's development.
Research finds prenatal cannabis exposure associated with elevated psychopathology, depression, anxiety, impulsivity, attention problems, social issues, sleep disturbances, and lower cognitive performance in middle childhood. Exposure after maternal knowledge of pregnancy also linked to child outcomes.
Hundreds of thousands of UK patients are self-medicating with illegal cannabis-based products due to limited prescription availability. Researchers found that concerns about a perceived lack of scientific evidence and resistance from the medical profession hinder prescribing, despite substantial evidence of effectiveness in various dis...
The percentage of college students who said they vaped marijuana in the past 30 days increased from 5.2% in 2017 to 14% in 2019, while those who used nicotine rose from 6.1% in 2017 to 22% in 2019. Daily or near-daily use of marijuana also increased among non-college attendees.
A new study suggests UK police are neglecting to recognize modern slavery in cannabis farm cases, where migrants are forced into illegal work. Researchers argue that arresting officers often lack detailed training on modern slavery and make only cursory enquiries.
A UBCO study examined pain tolerance among frequent cannabis users and found no association with increased sensitivity to pain. The research suggests that cannabis may be a safer alternative to opioids for managing chronic pain, offering hope for patients seeking relief.
A new study published in the journal Addiction found that moderate cannabis use during adolescence can have adverse effects on cognitive function, especially verbal memory. The study compared siblings to account for environmental and genetic factors, shedding light on the potential risks of cannabis use on developing brains.
A study from Yale School of Public Health found that higher rates of e-cigarette and marijuana use were associated with fewer vaping-related lung injuries. The study suggests that well-established markets for these substances may have crowded out the use of riskier, informally sourced e-liquids that drove the outbreak.
A new THC Rapid Field Test Kit developed by Purdue University and Hemp Synergistics allows law enforcement to distinguish hemp from marijuana in under five minutes, accurately measuring THC levels. This tool is expected to lower forensic laboratory submissions of suspected marijuana cases by 50%.
A study published in JAMA Network Open examines the association between depression and cannabis use among US adults. The analysis reveals a significant positive trend between cannabis use and depression, with the correlation strengthening over time.
A new study found that adults with sickle cell disease who received medical marijuana required fewer hospital visits than those who did not. Receiving medical marijuana was also associated with an increase in the use of edible cannabis products, which may help individuals better tolerate their pain at home.
A recent study by Dr. Jeremy Bernerth and H. Jack Walker found that using cannabis after work hours does not compromise job performance as assessed by supervisors. In fact, the researchers suggest that after-hours cannabis use may offer some work-related benefits, such as helping employees relax and restore energy after a long day.
A large study has found a link between cannabis use during pregnancy and an increased risk of autism in children. The study, published in Nature Medicine, looked at data from over 500,000 women in Ontario and found that children exposed to cannabis in utero were at greater risk of developing autism.
A phase 2a trial of 82 people investigated whether cannabidiol (CBD) is safe and can help people with cannabis use disorder reduce cannabis use. The study found that daily prescribed medical-use CBD use can cause reduction in cannabis use among people with cannabis use disorder.
A randomized clinical trial found that prescribed doses of non-intoxicating CBD reduced cannabis use and increased abstinence days. Participants treated with 400mg or 800mg CBD showed lower levels of cannabis in their urine and more days abstinent compared to placebo.
A new study from the University of Washington found that teens may be more likely to use marijuana following legalization due to increased adult use and store proliferation. The study's lead author notes that early use during adolescence can have negative health consequences, making it concerning that teen use may be going up.
A new clinical trial suggests that vaporized cannabis is safe and potentially effective in mitigating chronic pain caused by sickle cell disease. The study found that patients experienced reduced pain levels and improved mood over time, paving the way for further research on medical cannabis as a treatment option.
Experts argue that New Zealand's proposed cannabis legislation lacks clear criteria for minimum price and potency levels, posing challenges in reducing cannabis use over time and taxing products by THC potency. The bill needs strengthening to address these gaps and ensure a comprehensive regulatory framework.
The Medical Cannabis Real-World Evidence (MC-RWE) clinical trial aims to provide high-quality medical cannabis products with standardized potency and purity. Patients will have access to various products through an online portal, allowing them to track their consumption and effectiveness.
Research reveals that cannabis exposure leads to dysfunction of glucose metabolism in astrocytes, compromising neuronal functioning and resulting in reduced social interactions. The study sheds light on the link between cannabis use and sociability, highlighting potential therapeutic solutions.
The study identified fluctuations in brain network connectivity during cravings, particularly between reward-related regions such as the central executive network and the nucleus accumbens. These dynamic patterns are associated with cannabis use disorder severity and can be used as biomarkers for treatment strategies.
A University of Colorado Boulder study found that mothers who used marijuana during pregnancy were more likely to report their children having clinical sleep problems. The researchers also discovered that frequent marijuana use was associated with somnolence symptoms in children, such as excessive tiredness and difficulty waking up.
A pilot study found that cannabidiol significantly reduced irritability, aggression, self-injury, and yelling in children and adolescents with intellectual disabilities. The intervention was safe and well-tolerated by most participants, providing hope for a larger-scale trial to definitively test its effectiveness.
Recent studies examined the association between recreational marijuana legalization and changes in traffic fatality rates. The research found a significant decrease in traffic fatalities after states legalized cannabis use.
A new study published in Annals of Internal Medicine finds that a 4-month rifampin regimen is cheaper and more effective than a 9-month course of isoniazid for treating latent tuberculosis. The treatment has the potential to change the way latent tuberculosis is treated, with significant cost savings for healthcare systems.
A lack of reliable data on marijuana use hinders public health research in US states where cannabis has been legalized. Researchers found significant gaps in data availability, particularly for adolescent use and perceptions of cannabis.
A new study found that most cannabis poisoning incidents among children involved intentional use of cannabis combined with alcohol, illicit drugs, or medication. The majority of cases were reported on weekdays, with youth smoking cannabis and drinking alcohol in private residences.